Luba Greenwood - 16 Sep 2024 Form 4 Insider Report for Traws Pharma, Inc. (TRAW)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TRAW	Stock Option (Right to Purchase)	Award	$0	+164,000		$0.000000	164,000	16 Sep 2024	Common Stock	164,000	$0.3400	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	These options vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.